Open AccessVitamin D, Zinc and Iron in Adult Patients with Covid-19 and Their Action in the Immune Response as Biomarkers
Author(s) -
Eliza Miranda Ramos,
Emerson Luiz Lima Araújo,
Francisco José Mendes dos Reis,
Igor Domingos de Souza,
Gilberto Gonçalves Facco,
Iara Barbosa Ramos,
Pamella Aline Miranda Teodoro,
Antônio Carlos de Abreu,
Alessandro Carvalho da Fonseca,
Ernani Mendes da Fonseca,
Valter Aragão do Nascimento
Publication year - 2021
Publication title -
global journal of health science
Language(s) - English
Resource type - Journals
eISSN - 1916-9744
pISSN - 1916-9736
DOI - 10.5539/gjhs.v14n1p1
Subject(s) - medicine , covid-19 , immune system , incidence (geometry) , vitamin c , biomarker , vitamin d and neurology , zinc , adverse effect , vitamin , disease , immunology , intensive care medicine , infectious disease (medical specialty) , biology , biochemistry , physics , materials science , metallurgy , optics
COVID-19 in 2020 brought challenges to the Brazilian public health system with an emerging virus with respiratory contagion called SARS-CoV-2. There are few studies in Brazil and in some countries, on the increased incidence of certain viral respiratory infections, including H1N1 and coronavirus and their association with low levels of vitamin D, zinc and iron. The aim of this study was to demonstrate that the deficit of vitamin D, zinc and iron has an impact on the infectious process of patients with COVID-19 and to establish new forms of prevention for the worsening of COVID-19 in the human body. Data were collected from medical records and test results from patients being followed up during the treatment period for COVID-19. Patients with low blood levels of vitamin D, zinc and iron during the treatment period of COVID-19 had a higher percentage of worsening and complications requiring hospitalization in intensive care beds. The ingestion of vitamin D, zinc and iron in the treatment period of patients with COVID-19 in addition to being an immunological protector against SARS-CoV-2 and alleviating the process of worsening the disease can also act as a biomarker in cases of this disease.